Posts With Tag NASDAQ SGMO

Showing 1 - 1 of 1 Post

Sangamo Therapeutics, Inc. 8-K Report Summary - December 22, 2024 Insights

•

Form 8-K

•

2024-12-30

Last updated: 4 months ago

Sangamo Therapeutics, Inc. 8-K Report Summary - December 22, 2024 Insights

Explore the key insights from Sangamo Therapeutics, Inc.'s 8-K filing on December 22, 2024, covering stock details and SEC filing information.

Sangamo Therapeutics biotechnology NASDAQ SGMO 8-K filing Delaware corporations